Network meta-analysis of success rate and safety in antibiotic treatments of bronchitis

References

• PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
   PubMed Web of Science ®Google Scholar
• ZervosMJHeyderAMLeroyBOral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitisJ Int Med Res200331315716912870368
   PubMed Web of Science ®Google Scholar
• MandellGLBennettJEDolinRBook Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Volumes 1 and 24th edChurchill Livingstone1995
   Google Scholar
• SchabergTBallinIHuchonGBassarisHHampelBReimnitzPA multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitisJ Int Med Res200129431432811675905
   PubMed Web of Science ®Google Scholar
• DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• FalagasMEAvgeriSGMatthaiouDKDimopoulosGSiemposIIShort- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysisJ Antimicrob Chemother200862344245018467303
   PubMed Web of Science ®Google Scholar
• ZervosMMartinezFJAmsdenGWRothermelCDTreadwayGEfficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitisInt J Antimicrob Agents2007291566117189096
   PubMed Web of Science ®Google Scholar
• BuchananJBuchananWWMelroseAGMcGJPriceAULong-term prophylactic administration of tetracycline to chronic bronchiticsLancet19582704971972313588985
   PubMed Web of Science ®Google Scholar
• WilsonRAllegraLHuchonGShort-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitisChest2004125395396415006954
   PubMed Web of Science ®Google Scholar
• DeAbateCAMathewCPWarnerJHHeydAChurchDThe safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitisRespir Med200094111029103711127487
   PubMed Web of Science ®Google Scholar
• ChodoshSDeAbateCAHaverstockDAneiroLChurchDShort-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study GroupRespir Med2000941182710714475
   PubMed Web of Science ®Google Scholar
• MartinotJBCarrWDCullenSA comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitisAdv Ther200118111111512528
   PubMed Web of Science ®Google Scholar
• JohnstonRNLockhartWSmithDHCadmanNKA trial of phenethicillin in chronic bronchitisBr Med J19612525898598614452159
   PubMed Web of Science ®Google Scholar
• WilsonRSchentagJJBallPMandellLA comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomesClin Ther200224463965212017408
   PubMed Web of Science ®Google Scholar
• De VliegerADruartMPuttemansMRoxithromycin versus doxycycline in the treatment of acute exacerbations of chronic bronchitisDiagn Microbiol Infect Dis1992154 Suppl123S127S1617923
   PubMed Web of Science ®Google Scholar
• LeoneGLanzaRPaolettiVParlapianoCVincentelliGMA clinical trial of co-trimazine (sulfadiazine + trimethoprim) in flare-ups of chronic bronchitisJ Int Med Res1984121196363154
   PubMed Web of Science ®Google Scholar
• GilliesMRanakusumaAHoffmannTCommon harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indicationCMAJ20151871E21E3125404399
   PubMed Web of Science ®Google Scholar
• BentSSaintSVittinghoffEGradyDAntibiotics in acute bronchitis: a meta-analysisAm J Med19991071626710403354
   PubMed Web of Science ®Google Scholar
• SiemposIIDimopoulosGKorbilaIPMantaKFalagasMEMacrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysisEur Respir J20072961127113717301097
   PubMed Web of Science ®Google Scholar
• LiuKXXuBWangJEfficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysisJ Thorac Dis20146322122924624286
   PubMed Web of Science ®Google Scholar
• MiravitllesMMolinaJBrosaMClinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysisArch Bronconeumol2007431222817257560
   PubMed Web of Science ®Google Scholar
• KorbilaIPMantaKGSiemposIIDimopoulosGFalagasMEPenicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: meta-analysis of randomized controlled trialsCan Fam Physician2009551606719155372
   PubMed Web of Science ®Google Scholar
• ZhangLWangRFalagasMEChenLALiuYNGemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trialsChin Med J (Engl)2012125468769522490497
   PubMed Web of Science ®Google Scholar
• ZhuGQZouZLZhengJNSystematic review and network meta-analysis of randomized controlled trials: comparative effectiveness and safety of direct-acting antiviral agents for treatment-naive hepatitis C genotype 1Medicine (Baltimore)2016959e300426945424
   PubMed Web of Science ®Google Scholar
• ZhaoBCJiangHYMaWYAlbendazole and corticosteroids for the treatment of solitary cysticercus granuloma: a network meta-analysisPLoS Negl Trop Dis2016102e000441826849048
   PubMed Web of Science ®Google Scholar
• ZhangMYZhuGQShiKQSystematic review with network meta-analysis: comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivationOncotarget2016721306423065827121321
   PubMedGoogle Scholar
• VeronikiAAStrausSEAshoorHMComparative safety and effectiveness of cognitive enhancers for Alzheimer’s dementia: protocol for a systematic review and individual patient data network meta-analysisBMJ Open201661e010251
   Web of Science ®Google Scholar
• TveteIFNatvigBGasemyrJMelandNRoineMKlempMCorrection: comparing effects of biologic agents in treating patients with rheumatoid arthritis: a multiple treatment comparison regression analysisPLoS One2016111e014663326812687
   PubMed Web of Science ®Google Scholar
• BlasiFTarsiaPManteroMMorlacchiLCPifferFCefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradicationTher Clin Risk Manag20139556423430960
   PubMed Web of Science ®Google Scholar
• MartinezFJGrossmanRFZadeikisNPatient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mgEur Respir J20052561001101015929954
   PubMed Web of Science ®Google Scholar
• StarakisIGogosCABassarisHFive-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitisInt J Antimicrob Agents200423212913715013037
   PubMed Web of Science ®Google Scholar
• WilsonRLanganCBallPOral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitisRespiratory Medicine200397324224912645831
   PubMed Web of Science ®Google Scholar
• SolerMLodeHBaldwinRRandomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic bronchitisEur J Clin Microbiol Infect Dis200322314415012649711
   PubMed Web of Science ®Google Scholar
• AmsdenGWBairdIMSimonSTreadwayGEfficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitisChest2003123377277712628877
   PubMed Web of Science ®Google Scholar
• WeissLROpen-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitisClin Ther20022491414142512380633
   PubMed Web of Science ®Google Scholar
• GrassiCCasaliLCurtiETellariniMLazzaroCSchitoGEfficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB)J Chemother200214659760812583552
   PubMed Web of Science ®Google Scholar
• AubierMAldonsPMLeakATelithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitisRespir Med2002961186287112418583
   PubMed Web of Science ®Google Scholar
• GotfriedMHDeAbateCAFogartyCMathewCPSokolWNComparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitisClin Ther20012319710711219483
   PubMed Web of Science ®Google Scholar
• AnzuetoAFisherCLJrBusmanTOlsonCAComparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitisClin Ther2001231728611219481
   PubMed Web of Science ®Google Scholar
• SchouenborgPGerdesNRasmussenHWickers-NielsenNMathiassenEAzithromycin versus pivampicillin in the treatment of acute exacerbations of chronic bronchitis: a single-blind, double-dummy, multicentre studyJ Int Med Res200028310111010983860
   PubMed Web of Science ®Google Scholar
• KreisA comparison of moxifloxacin and azithromycin in the treatment of acute exacerbations of chronic bronchitisJ Clin Outcomes Manag20007123337
   Google Scholar
• FileTSchlemmerBGarauJLodeHLynchSYoungCGemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study groupJ Chemother200012431432510949981
   PubMed Web of Science ®Google Scholar
• WilsonRKubinRBallinIFive day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitisJ Antimicrob Chemother199944450151310588312
   PubMed Web of Science ®Google Scholar
• LanganCEZuckPVogelFRandomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitisJ Antimicrob Chemother199944451552310588313
   PubMed Web of Science ®Google Scholar
• Van RoyenPBetzWHeyrmanJTaziauxPVan den HauteMPoelmanMDirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitisJ Int Med Res199725133409027671
   PubMed Web of Science ®Google Scholar
• HoepelmanIMMollersMJvan SchieMHA short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcomeInt J Antimicrob Agents1997931411469552709
   PubMed Web of Science ®Google Scholar
• ZachariahJA randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infectionsJ Antimicrob Chemother199637Suppl C1031138818851
   PubMed Web of Science ®Google Scholar
• GrisPOnce-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative studyJ Antimicrob Chemother199637Suppl C93101
   Web of Science ®Google Scholar
• SachsAPKoeterGHGroenierKHvan der WaaijDSchiphuisJMeyboom-de JongBChanges in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practiceThorax19955077587637570411
   PubMed Web of Science ®Google Scholar
• BeghiGBerniFCarratuLEfficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitisJ Chemother1995721461527666122
   PubMed Web of Science ®Google Scholar
• VerheijTJHermansJMulderJDEffects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trialBr J Gen Pract1994443864004048790652
   PubMed Web of Science ®Google Scholar
• UlmerWFleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitisAm J Med1993943A136S141S8452170
   PubMedGoogle Scholar
• ChodoshSEfficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitisAm J Med1993943A131S135S8452169
   PubMedGoogle Scholar
• MertensJCvan BarneveldPWAsinHRDouble-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitisAntimicrob Agents Chemother1992367145614591324645
   PubMed Web of Science ®Google Scholar
• GuayDRCraftJCComparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitisJ Intern Med199223132953011532615
   PubMed Web of Science ®Google Scholar
• DautzenbergBScheimbergABrambillaCComparison of two oral antibiotics, roxithromycin and amoxicillin plus clavulanic acid, in lower respiratory tract infectionsDiagn Microbiol Infect Dis1992154 Suppl85S89S1617930
   PubMed Web of Science ®Google Scholar
• BachandRTJrComparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitisJ Antimicrob Chemother199127Suppl A91100
   PubMed Web of Science ®Google Scholar
• AldonsPMA comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitisJ Antimicrob Chemother199127Suppl A1011081827095
   PubMed Web of Science ®Google Scholar
• GoveRICaytonRMA double-blind comparison of amoxycillin with trimethoprim in acute exacerbations of chronic bronchitisJ Antimicrob Chemother19851544954993891710
   PubMed Web of Science ®Google Scholar
• LalSMcGhieDKerfootPA comparison of pivmecillinam/pivampicillin and co-trimoxazole in hospitalized patients with acute exacerbations of chronic bronchitisJ Antimicrob Chemother19841421791846334071
   PubMed Web of Science ®Google Scholar
• AndersonGWilliamsLPardoeTPeelETCo-trimoxazole versus cefaclor in acute on chronic bronchitisJ Antimicrob Chemother1981864874896977523
   PubMed Web of Science ®Google Scholar
• DaviesDDarkeCSSulfametopyrazine prophylaxis in chronic bronchitisBr J Dis Chest1978723231234359024
   PubMedGoogle Scholar
• PinesANandiARRaafatHRahmanMAmoxycillin and co-trimoxazole in acute purulent exacerbations of chronic bronchitisChemotherapy19772315864
   Web of Science ®Google Scholar
• StottNCWestRRRandomised controlled trial of antibiotics in patients with cough and purulent sputumBr Med J197626035556559786428
   PubMed Web of Science ®Google Scholar
• HeebSFletcherMPChhabraSRDiggleSPWilliamsPCamaraMQuinolones: from antibiotics to autoinducersFEMS Microbiol Rev201135224727420738404
   PubMed Web of Science ®Google Scholar
• IvanovDVBudanovSVCiprofloxacin and antibacterial therapy of respiratory tract infectionsAntibiot Khimioter20065152937
   Google Scholar
• HooperDCEmerging mechanisms of fluoroquinolone resistanceEmerg Infect Dis20017233734111294736
   PubMed Web of Science ®Google Scholar
• TensonTLovmarMEhrenbergMThe mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosomeJ Mol Biol200333051005101412860123
   PubMed Web of Science ®Google Scholar
• DrainasDKalpaxisDLCoutsogeorgopoulosCInhibition of ribosomal peptidyltransferase by chloramphenicol. Kinetic studiesEur J Biochem1987164153583549307
   PubMedGoogle Scholar
• DimopoulosGSiemposIIKorbilaIPMantaKGFalagasMEComparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trialsChest2007132244745517573508
   PubMed Web of Science ®Google Scholar
• ShehabNPatelPRSrinivasanABudnitzDSEmergency department visits for antibiotic-associated adverse eventsClin Infect Dis200847673574318694344
   PubMed Web of Science ®Google Scholar
• SathasivamSLeckyBStatin induced myopathyBMJ2008337a228618988647
   PubMed Web of Science ®Google Scholar
• AlbertRHDiagnosis and treatment of acute bronchitisAm Fam Physician201082111345135021121518
   PubMed Web of Science ®Google Scholar
• BruntonSCarmichaelBPColganRAcute exacerbation of chronic bronchitis: a primary care consensus guidelineAm J Manag Care2004101068915521160
   PubMed Web of Science ®Google Scholar
• LivermoreDMFourteen years in resistanceInt J Antimicrob Agents201239428329422386741
   PubMed Web of Science ®Google Scholar
• AndradeSSDGalesACSaderHSAntimicrobial resistance in gram-negative bacteria from developing countriesSosaA de JByarugabaDKAmabileCHsuehPRKariukiSOkekeINAntimicrobial Resistance in Developing CountriesNew YorkSpringer-Verlag2010249266
   Google Scholar
• LokeYKPriceDHerxheimerASystematic reviews of adverse effects: framework for a structured approachBMC Med Res Methodol200773217615054
   PubMed Web of Science ®Google Scholar